Upregulation of stromal cell–derived factor 1 (SDF-1) expression in microvasculature endothelial cells in retinal ischemia-reperfusion injury
✍ Scribed by Pinghong Lai; Tao Li; Jun Yang; Chengyang Xie; Xiaobo Zhu; Hui Xie; Xiaoyan Ding; Shaofen Lin; Shibo Tang
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 314 KB
- Volume
- 246
- Category
- Article
- ISSN
- 0065-6100
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Giant cell tumor (GCT) of bone is a unique bone lesion that is characterized by an excessive number of multinucleated osteoclasts. GCT consists of neoplastic stromal cells, multinucleated osteoclasts and their precursors, thus serving as a naturally occurring human disease model for the
## Abstract α‐chemokines, which control the activation and directed migration of leukocytes, participate in the inflammatory processes in host defense response. One of the α‐chemokines, CXCL12 or stromal cell‐derived factor 1 (SDF‐1), not only regulates cell growth and migration of hematopoietic st
Transforming growth factor-1 (TGF-1) regulates a variety of cellular functions. In several types of cells, for example, it acts as a growth inhibitor and an inducer of apoptotic cell death. Although one of the important modulators in retinal vascular development and retinal neovascularization, the
## Abstract Stromal cell‐derived Factor‐1α (SDF‐1α) stimulates the migration of bone marrow (BM) cells, similar to vascular endothelial growth factor (VEGF). We previously demonstrated that inhibition of VEGF~165~ by small interfering RNA inhibited Ewing's sarcoma tumor growth, tumor vessel formati